Clinical trial
Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients…
NCT00050167 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00050167 |
|---|---|
| Title | Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer |
| Official title | Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | Roche Pharma AG Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Paclitaxel, Docetaxel, Capecitabine |
| Enrollment | 603 |
| Start date | Nov 1, 2002 |
| Primary completion | Jul 1, 2008 |
| Completion | Aug 1, 2011 |
| First posted | Nov 27, 2002 |
| Last update posted | Aug 29, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: